The CSNK1A1 Knockout Raji Polyclonal Cells comprise a population of Raji cells with targeted disruption of the CSNK1A1 gene via CRISPR/Cas9-mediated genome editing. This polyclonal knockout model provides a heterogeneous loss-of-function system to study casein kinase 1 alpha (CK1??) function in a human B lymphocyte background. The product is supplied as a pool of edited cells, enabling researchers to assess the collective impact of CSNK1A1 deficiency on downstream signaling, cell proliferation, and apoptosis without selection of a single clonal isolate.
Raji cells are an Epstein-Barr virus (EBV)-positive lymphoblastoid cell line derived from a human male Burkitt lymphoma patient. These B lymphocytes are widely employed in immunological and oncological investigations, particularly for studying B-cell malignancies, receptor signaling, and apoptosis. The EBV-positive status and characteristic chromosomal translocations of Raji cells provide a clinically relevant backdrop for examining the interplay between viral latency and cellular signaling pathways, including those governed by CK1??.
Casein kinase 1 alpha, encoded by CSNK1A1, is a serine/threonine kinase that serves as a central regulator of multiple signaling networks. CK1?? phosphorylates ??-catenin (CTNNB1) within the destruction complex, promoting its proteasomal degradation and thereby restraining Wnt/??-catenin signaling. It also phosphorylates p53 (TP53) to modulate DNA damage responses and phosphorylates circadian clock proteins PER1 and PER2, linking Wnt and circadian pathways. Upstream, CK1?? is activated by Wnt pathway stimulation and integrates into the AXIN1/APC/GSK-3?? destruction complex, while DNA damage-activated ATM/ATR can modulate CK1??-mediated p53 phosphorylation. Additionally, CK1?? participates in Hedgehog signaling and circadian transcriptional feedback loops.
In the Raji B lymphocyte context, disruption of CSNK1A1 abrogates CK1??-dependent phosphorylation of ??-catenin and p53, leading to stabilization and nuclear accumulation of ??-catenin, and altered p53-dependent cell cycle control and apoptosis. This knockout model thereby mimics oncogenic activation of Wnt signaling often observed in B-cell lymphomas and provides a platform to dissect CK1??’s tumor-suppressive roles. The EBV-positive background further allows investigation of how viral proteins intersect with CK1??-regulated pathways, potentially revealing mechanisms of lymphomagenesis and viral persistence.
Researchers can utilize these polyclonal CSNK1A1 knockout Raji cells in a range of functional assays. Western blotting for CSNK1A1 and phospho-??-catenin confirms target disruption, and RT-qPCR quantifies downstream targets such as MYC and CCND1. TOP/FOPflash luciferase reporters assess ??-catenin-driven transcription. Flow cytometry with Annexin V/PI staining reveals apoptotic changes, while MTT or CFSE proliferation assays measure growth. Co-immunoprecipitation can examine CK1?? interactions with AXIN1 or APC. These applications support studies on Wnt/??-catenin signaling in Burkitt lymphoma, CK1?? inhibitor screening, and circadian disruption in B-cell malignancies. For additional technical details, please contact Ascent Research.
